Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04741009 · ClinicalTrials.gov registry record · NA
Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing
A NA study of Sensorineural Hearing Loss and Low-Frequency Residual Hearing, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 4
- Study locations
NCT04741009: Completed NA study of Sensorineural Hearing Loss and Low-Frequency Residual Hearing, sponsored by Cochlear.
NCT04741009 is a NA study of Sensorineural Hearing Loss and Low-Frequency Residual Hearing that has completed, run by Cochlear. The registered enrollment target is 10 participants, below the 130-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04741009, a NA study of Sensorineural Hearing Loss and Low-Frequency Residual Hearing, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI632 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.
Primary Outcome
To characterize hearing performance of the CI632 using the Consonant-Nucleus-Consonant (CNC) monosyllabic word recognition test in quiet (unilateral). Two CNC word lists will be administered at a level equal to 60 dBA in the sound field and scored as a total number of words correct, expressed as a percentage correct.
Conditions Studied
Interventions
- DEVICE CI632 Slim Modiolar Electrode
Study Locations (4)
Ohio
- Cleveland Clinic - Cleveland
- University Hospitals - Cleveland
Massachusetts
- UMass Memorial Medical Center - Worcester
Missouri
- Midwest Ear Institute - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-12-16 |
| Est. Completion | 2025-06-16 |
| Phase | NA |
What the finished NCT04741009 record still lists
NCT04741009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 130-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which CI632 Slim Modiolar Electrode is the first listed.
NCT04741009 reports a single indexed study location in Ohio, Massachusetts, Missouri.
Frequently Asked Questions
What is clinical trial NCT04741009 about?
NCT04741009 is a clinical study titled "Perimodiolar Implant Performance in Adults With Low-Frequency Residual Hearing". The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI632 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.
What is the current status of trial NCT04741009?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-12-16. Estimated completion is 2025-06-16.
What conditions does trial NCT04741009 study?
This clinical trial studies the following conditions: Sensorineural Hearing Loss, Low-Frequency Residual Hearing.
What interventions are being tested in trial NCT04741009?
The interventions under investigation include: CI632 Slim Modiolar Electrode (DEVICE).
Who is sponsoring clinical trial NCT04741009?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04741009 being conducted?
This trial has 4 study locations across Massachusetts, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sensorineural Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04741009's enrollment target sits among peer trials
10 14th of 13 the lowest of 13 other Sensorineural Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sensorineural Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Perceptual Adaptation Following Cochlear Implantation (Aim 3a)
RECRUITING · NA
-
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
RECRUITING · NA
-
Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning
RECRUITING · NA
-
Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant
ACTIVE NOT RECRUITING · NA
-
The Effect of Sound Stimulation on Pure-tone Hearing Threshold
COMPLETED · NA
-
Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI